Trademark Search  /  CTX320

CTX320

● Live · Pending

U.S. federal trademark · Serial No. 97461218

Mark
CTX320
Status
Pending
Serial Number
97461218
Filing Date
June 16, 2022
Class(es)
Class 005, Class 042

Owners

CRISPR Therapeutics AG
99 · ZUG V8 SWITZERLAND, CH
CRISPR Therapeutics AG
99 · ZUG V8 SWITZERLAND, CH

Goods & Services

Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of in vivo gene editing therapy; gene editing, namely, pharmaceutical research and development in the field of in vivo gene editing therapy

Cells for medical or clinical use in the field of in vivo gene editing therapy for the treatment of cardiovascular diseases; pharmaceutical and biopharmaceutical agents for the treatment of cardiovascular disease in the field of in vivo gene editing therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cardiovascular disease in the field of in vivo gene editing therapy

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "CTX320" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.